Gland clinical trials

Explore recruiting gland clinical trials.

Recruiting gland studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Gland trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Prevention of radiation-induced salivary gland damage by botulinum toxin application in patients with head and neck cancers

Czechia

Therapeutic exploratory (Phase II) EU CTIS Study details

PENTALON - Pilot study for the evaluation of [68Ga]Ga-PentixaFor PET imaging for the identification of unilateral adrenal secretion of ALdosterON in patients with primary aldosteronism.

France

Phase II and Phase III (Integrated) EU CTIS Study details

RESTART; Autologous Transplantation of Adult Salivary Gland Stem Cells to Restore Submandibular Gland Function after Radiotherapy

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

An open-label, non-randomized, biopsy-based mechanistic study on pharmacokinetics, pharmacodynamics, safety and tolerability of ianalumab in patients with Sjögren's syndrome

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Sentinel lymph node biopsy in patients with parotid gland carcinoma using a combination of 99mTc-nanocolloid and 68Ga-tilmanocept PET/CT: A feasibility study. (SNparotis)

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prospective evaluation of the efficacy and safety of topical hydrocortisone treatment on clinical signs and symptoms of dry eye disease associated with moderate meibomian gland dysfunction

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Gland trials by city

Gland in Toronto Gland in Vancouver Gland in Montreal Gland in Calgary Gland in Edmonton Gland in Ottawa Gland in Winnipeg Gland in Quebec City Gland in Hamilton Gland in Kitchener Gland in London Gland in Halifax Gland in New York Gland in Los Angeles Gland in Chicago Gland in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease